Investigation and treatment of type 2 diabetes in nonhuman primates

Methods in Molecular Biology

Volumn 933, Issue , 2012, Pages 177-185

  Hansen, Barbara C ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Complications of diabetes; Cynomolgus (Macaca fascicularis); Insulin therapy; Metabolic syndrome; Monkeys; Nonhuman primates; Prediabetes; Rhesus (Macaca mulatta); Type 2 diabetes

Indexed keywords

INSULIN; METFORMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; INTRAVENOUS GLUCOSE TOLERANCE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIMATE; PRIORITY JOURNAL;

EID: 84934435442     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-68-7_11     Document Type: Article

References (36)

1. Hansen BC, Bodkin NL (1986) Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29:713-719
2. Hansen BC, Bodkin NL (1990) Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol 259:R612-R617
3. Ortmeyer HK, Bodkin NL, Hansen BC (1993) Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. Am J Physiol 265:R552-R558
4. Hotta K, Funahashi T, Bodkin NL et al (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133
5. Bodkin NL, Alexander TM, Ortmeyer HK et al (2003) Mortality and morbidity in laboratory- maintained Rhesus monkeys and effects of long-term dietary restriction. J Gerontol A Biol Sci Med Sci 58:212-219
6. Tigno XT, Gerzanich G, Hansen BC et al (2004) Age-related changes in metabolic parameters of nonhuman primates. J Gerontol A Biol Sci Med Sci 59:1081-1088
7. Ding SY, Tigno XT, Hansen BC et al (2007) Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. Metabolism 56:838-846
8. Cnop M, Hughes SJ, Igoillo-Esteve M et al (2010) The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53:321-330
9. Cusumano AM, Bodkin NL, Hansen BC et al (2002) Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. Am J Kidney Dis 40:1075-1085
10. Bauer SA, Leslie KE, Pearl DL et al (2010) Survey of prevalence of overweight body condition in laboratory-housed cynomolgus macaques (Macaca fascicularis). J Am Assoc Lab Anim Sci 49:407-414
11. Bauer SA, Leslie KE, Pearl DL et al (2010) Retrospective case-control study of hyperglycemia in group-housed, mature female cynomolgus macaques (Macaca fascicularis). J Med Primatol 39:408-416
12. Chavez AO, Lopez-Alvarenga JC, Tejero ME et al (2008) Physiological and molecular determinants of insulin action in the baboon. Diabetes 57:899-908
13. Guardado-Mendoza R, Dick EJ Jr, Jimenez- Ceja LM et al (2009) Spontaneous pathology of the baboon endocrine system. J Med Primatol 38:383-389
14. Perez VL, Caicedo A, Berman DM et al (2011) The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes. Diabetologia 54:1121-1126
15. McTighe MS, Hansen BC, Ely JJ et al (2011) Determination of hemoglobin A1c and fasting blood glucose reference intervals in captive chimpanzees (Pan troglodytes). J Am Assoc Lab Anim Sci 50(2):165-170
16. Winegar DA, Brown PJ, Wilkison WO et al (2001) Effects of fenofibrate on lipid parameters in obese rhesus monkeys. J Lipid Res 42(10):1543-1551
17. Schafer SA, Hansen BC, Volkl A et al (2004) Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR) alpha activator, in non-human primates. Biochem Pharmacol 68:239-251
18. Ding SY, Tigno XT, Braileanu GT et al (2007) A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys. Metabolism 56:1334-1339
19. Kharitonenkov A, Wroblewski VJ, Koester A et al (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor- Endocrinology 148:774-781
20. Kavanagh K, Brown KK, Berquist ML et al (2010) Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator- activated receptor-gamma agonist use in prediabetes. Metabolism 59:914-920
21. Wagner JD, Shadoan MK, Zhang L et al (2010) A selective peroxisome proliferatoractivated receptor alpha agonist, CP-900691, improves plasma lipids, lipoproteins, and glycemic control in diabetic monkeys. J Pharmacol Exp Ther 333:844-853
22. Hansen BC, Tigno XT, Benardeau A et al (2011) Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor alpha/gamma agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome. Cardiovasc Diabetol 10:7
23. Casu A, Bottino R, Balamurugan AN et al (2008) Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 51:120-129
24. Bottino R, Criscimanna A, Casu A et al (2009) Recovery of endogenous beta-cell function in nonhuman primates after chemical diabetes induction and islet transplantation. Diabetes 58(2):442-447
25. Rogers SA, Mohanakumar T, Liapis H et al (2010) Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats. Am J Pathol 177:854-864
26. Hammerman MR (2011) Engraftment of insulin-producing cells from porcine islets in non-immune-suppressed rats or nonhuman primates transplanted previously with embryonic pig pancreas. J Transplant 2011:261352
27. Kim SY, Johnson MA, McLeod DS et al (2005) Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes 54:1534-1542
28. Pare M, Albrecht PJ, Noto CJ et al (2007) Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes. J Comp Neurol 501:543-567
29. Najafian B, Masood A, Malloy PC et al (2011) Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study. Diabetes Metab Res Rev 27:341-347
30. National Research Council. (2011) Guide for the care and use of laboratory animals, 8th edn. The National Academies Press, Washington DC
31. Tigno XT, Ding SY, Hansen BC (2006) Paradoxical increase in dermal microvascular flow in pre-diabetes associated with elevated levels of CRP. Clin Hemorheol Microcirc 34:273-282
32. Tigno XT, Hansen BC, Nawang S et al (2011) Vasomotion becomes less random as diabetes progresses in monkeys. Microcirculation 18:429-439
33. Shamekh R, Linden EH, Newcomb JD et al (2011) Endogenous and diet-induced hypercholesterolemia in nonhuman primates: effects of age, adiposity, and diabetes on lipoprotein profiles. Metabolism 60:1165-1177
34. Hansen BC, Bodkin NL (1993) Primary prevention of diabetes mellitus by prevention of obesity in monkeys. Diabetes 42:1809-1814
35. Ortmeyer HK, Sajan MP, Miura A et al (2011) Insulin signaling and insulin sensitizing in muscle and liver of obese monkeys: peroxisome proliferator-activated receptor gamma agonist improves defective activation of atypical protein kinase C. Antioxid Redox Signal 14:207-219
36. Kemnitz JW, Elson DF, Roecker EB, et al (1994) Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes 43:204-211